Evidence map›Paper›PMID 31933696›Full record

ArticleJournal of cardiology cases2020

A case of severe peripartum cardiomyopathy requiring left ventricular assist device implantation despite the absence of late gadolinium enhancement on cardiovascular magnetic resonance imaging.

Chihiro Takuwa-Shiomi, Masataka Ogiso, Toshiaki Isogai, Ken Kato, Hiroyuki Tanaka, Takahiro Kiriu, Ai Masukawa, Hiroshi Niinami, Nobuhisa Hagiwara

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of cardiology cases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chihiro Takuwa-ShiomiDepartment of Cardiology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Masataka OgisoDepartment of Cardiology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Toshiaki IsogaiDepartment of Cardiology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Ken KatoDepartment of Cardiology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Hiroyuki TanakaDepartment of Cardiology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Takahiro KiriuDepartment of Pathology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Ai MasukawaDepartment of Radiology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Hiroshi NiinamiDepartment of Cardiovascular Surgery, Tokyo Women's Medical University, Tokyo, Japan.
Nobuhisa HagiwaraDepartment of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
Tokyo Metropolitan Tama Medical Center · JPTokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripartum cardiomyopathy (PPCM) is a rare disorder in which left ventricular (LV) systolic dysfunction and symptoms of heart failure (HF) occur in the peripartum period. The time to potential recovery from severe remodeling of ventricular function is difficult to predict. Although lack of late gadolinium enhancement (LGE) in cardiovascular magnetic resonance (CMR) is reportedly associated with functional recovery of the LV in some cardiomyopathies, the impact of LGE in PPCM remains unclear. We herein report a case of a patient with PPCM who demonstrated rapidly worsened ventricular function, leading to requirement of a paracorporeal left ventricular assist device (LVAD) implantation despite absence of LGE in CMR. A 34-year-old Japanese patient, G2P2A0, expecting her third delivery following a full-term pregnancy, experienced heart failure. Severe LV dysfunction and PPCM were diagnosed. CMR showed no LGE. Although standard HF therapy and bromocriptine were given, her cardiac function failed to recover, and she eventually underwent paracorporeal LVAD implantation as a bridge to heart transplantation due to the impossibility of stopping the administration of inotropic agents. <

Indexed as

Late gadolinium enhancementLeft ventricular assist devicePeripartum cardiomyopathy

Identifiers

PMID31933696
PMCPMC6951448
OpenAlexW2975959686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.